论文部分内容阅读
青霉素是当前世界卫生组织推荐的治疗淋病的首选药物。但近年来耐青霉素淋菌的出现和流行给淋病的防治工作带来了新问题,对耐青霉素淋病的治疗,已引起广泛注意。近4年来,我们用利福平和卡那霉素共治疗耐青霉素淋病26例,收到满意效果,报告如下。一、一般资料 26例淋病患者中,男21例,女5例;年龄最大的53岁,最小的13岁,多数在20至30岁。除13岁男孩患者的传染方式不明外,其余男女患者均有不洁性生活史。病史:21例男患者均有尿频尿痛及尿道口脓性分泌物;女性患者中有3例有尿道炎或下腹疼痛,但妇检发现均有阴道脓性分泌物。男性患者取尿道
Penicillin is currently recommended by the World Health Organization for the treatment of gonorrhea drug of choice. However, in recent years, the emergence and prevalence of penicillin-resistant gonorrhea have brought new problems to the prevention and treatment of gonorrhea. The treatment of penicillin-resistant gonorrhea has drawn extensive attention. In the past 4 years, we used rifampicin and kanamycin to treat 26 cases of penicillin-resistant gonorrhea, and received satisfactory results, the report is as follows. First, the general information 26 cases of gonorrhea patients, 21 males and 5 females; the oldest 53 years old, the youngest 13 years old, mostly in the 20 to 30 years old. In addition to the 13-year-old boy infected with unknown manner, the remaining men and women have a dirty life history. History: 21 cases of male patients had urinary frequency and painful urethral purulent secretions; 3 cases of female patients with urethritis or abdominal pain, but women found vaginal purulent secretions. Male patients take the urethra